StonvexLoading…
StonvexStonvexStonvexCore line items from BAK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | BRL 77.41B | BRL 70.57B | BRL 96.52B | BRL 105.63B |
Operating Income | BRL -1.08B | BRL -2.79B | BRL 4.27B | BRL 26.04B |
Net Income | BRL -12.05B | BRL -4.89B | BRL -821.00M | BRL 13.96B |
EPS (Diluted) | Not available | Not available | Not available | BRL 17.57 |
Total Assets | BRL 101.58B | BRL 91.74B | BRL 88.05B | BRL 92.56B |
Total Liabilities | Not available | Not available | BRL 3.01B | BRL 4.19B |
Cash & Equivalents | BRL 14.99B | BRL 14.19B | BRL 12.47B | BRL 8.68B |
Free Cash Flow OCF − CapEx | BRL -1.33B | BRL -6.80B | BRL 4.10B | BRL 11.37B |
Shares Outstanding | 797.21M | 797.21M | 797.21M | 797.21M |